These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12902917)

  • 1. Ovarian carcinoma in an adolescent with transgenerational exposure to diethylstilbestrol.
    Blatt J; Van Le L; Weiner T; Sailer S
    J Pediatr Hematol Oncol; 2003 Aug; 25(8):635-6. PubMed ID: 12902917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diethylstilbestrol exposure during pregnancy with primary clear cell carcinoma of the cervix in an 8-year-old granddaughter: a multigenerational effect of endocrine disruptors?
    Gaspari L; Paris F; Cassel-Knipping N; Villeret J; Verschuur A; Soyer-Gobillard MO; Carcopino-Tusoli X; Hamamah S; Kalfa N; Sultan C
    Hum Reprod; 2021 Jan; 36(1):82-86. PubMed ID: 33147330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse health effects in children of women exposed in utero to diethylstilbestrol (DES).
    Tournaire M; Epelboin S; Devouche E; Viot G; Le Bidois J; Cabau A; Dunbavand A; Levadou A
    Therapie; 2016 Sep; 71(4):395-404. PubMed ID: 27203157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear cell adenocarcinoma of the ovary associated with in utero diethylstilbestrol exposure: case report and clinical overview.
    Dasanu CA; Herzog TJ
    Medscape J Med; 2009; 11(1):6. PubMed ID: 19295927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure.
    Wise LA; Palmer JR; Rowlings K; Kaufman RH; Herbst AL; Noller KL; Titus-Ernstoff L; Troisi R; Hatch EE; Robboy SJ
    Obstet Gynecol; 2005 Jan; 105(1):167-73. PubMed ID: 15625159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
    Blythe JG; Michael H; Hodel KA
    J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uterus and diethylstilbestrol: which examinations, which antecedents for an active management? Which treatments?].
    Aubriot FX; Chapron C; Dubuisson JB; Hamou JE
    Contracept Fertil Sex; 1998; 26(7-8):598-604. PubMed ID: 9810140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Consequences of diethylstilbestrol during pregnancy; 50 years later still a significant problem].
    Treffers PE; Hanselaar AG; Helmerhorst TJ; Koster ME; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2001 Apr; 145(14):675-80. PubMed ID: 11530703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero.
    Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA
    Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development.
    Baird DD; Newbold R
    Reprod Toxicol; 2005; 20(1):81-4. PubMed ID: 15808789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the Effects of DES Over? A Tragic Lesson from the Past.
    Zamora-León P
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear cell renal carcinoma in a pregnant DES-exposed patient.
    Mansi ML
    J Am Osteopath Assoc; 1989 Jul; 89(7):929-32. PubMed ID: 2768009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES).
    Herbst AL
    Gynecol Oncol; 2000 Feb; 76(2):147-56. PubMed ID: 10637063
    [No Abstract]   [Full Text] [Related]  

  • 14. [Female fertility prognosis and diethylstilbestrol. Personal data and review of the literature].
    Laurent S; Lanoue M; Lecomte C; Bourgeois L; Lecomte P
    J Gynecol Obstet Biol Reprod (Paris); 1998 Apr; 27(3):277-84. PubMed ID: 9648005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal papillary serous carcinoma in a woman with a history of utero DES exposure.
    Seoud MA; Tawfik O; Hunter V
    Gynecol Oncol; 1993 Sep; 50(3):371-3. PubMed ID: 8406204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cystadenofibromas in three women with antenatal exposure to diethylstilbestrol.
    Schmidt G; Fowler WC
    Gynecol Oncol; 1982 Oct; 14(2):175-84. PubMed ID: 7129213
    [No Abstract]   [Full Text] [Related]  

  • 17. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary tumors in mice exposed prenatally to diethylstilbestrol.
    Walker BE; Kurth LA
    Cancer Res; 1993 Apr; 53(7):1546-9. PubMed ID: 8453621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural changes of the genital tract associated with in utero exposure to diethylstilbestrol.
    Kaufman RH
    Obstet Gynecol Annu; 1982; 11():187-202. PubMed ID: 7110645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The National DES Education Program: effectiveness of the California Health Provider Intervention.
    Cohn BA; Wingard DL; Patterson RC; McPhee SJ; Gerbert B
    J Cancer Educ; 2002; 17(1):40-5. PubMed ID: 12000106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.